557 related articles for article (PubMed ID: 28040311)
1. Foot-and-mouth disease vaccines.
Diaz-San Segundo F; Medina GN; Stenfeldt C; Arzt J; de Los Santos T
Vet Microbiol; 2017 Jul; 206():102-112. PubMed ID: 28040311
[TBL] [Abstract][Full Text] [Related]
2. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
Rodriguez LL; Gay CG
Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
[TBL] [Abstract][Full Text] [Related]
3. Targeted FMD Vaccines for Eastern Africa: The AgResults Foot and Mouth Disease Vaccine Challenge Project.
Hammond JM; Maulidi B; Henning N
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578411
[TBL] [Abstract][Full Text] [Related]
4. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
[TBL] [Abstract][Full Text] [Related]
5. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
6. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
8. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
[TBL] [Abstract][Full Text] [Related]
9. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
10. Serosurveillance for foot-and-mouth disease in Mongolian gazelles (Procapra gutturosa) and livestock on the Eastern Steppe of Mongolia.
Bolortsetseg S; Enkhtuvshin S; Nyamsuren D; Weisman W; Fine A; Yang A; Joly DO
J Wildl Dis; 2012 Jan; 48(1):33-8. PubMed ID: 22247371
[TBL] [Abstract][Full Text] [Related]
11. Developing Vaccines Against Foot-and-Mouth Disease: a Biotechnological Approach.
Shahriari A; Habibi-Pirkoohi M
Arch Razi Inst; 2018 Dec; 73(1):1-10. PubMed ID: 30256033
[TBL] [Abstract][Full Text] [Related]
12. The impact of changing farm structure on foot-and-mouth disease spread and control: A simulation study.
Halasa T; Ward MP; Boklund A
Transbound Emerg Dis; 2020 Jul; 67(4):1633-1644. PubMed ID: 32012445
[TBL] [Abstract][Full Text] [Related]
13. Foot-and-mouth disease: past, present and future.
Jamal SM; Belsham GJ
Vet Res; 2013 Dec; 44(1):116. PubMed ID: 24308718
[TBL] [Abstract][Full Text] [Related]
14. Biosecurity and FMD transmission.
Dekker A
Vet Rec; 2011 Feb; 168(5):126-7. PubMed ID: 21493485
[No Abstract] [Full Text] [Related]
15. Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
Lyons NA; Knight-Jones TJD; Bartels C; Paton DJ; Ferrari G; Vermillion MS; Brooks AW; Motroni R; Parker E; Hefferin Berquist ML; Sumption KJ; Klement E
Vaccine; 2019 Feb; 37(8):1007-1015. PubMed ID: 30685245
[TBL] [Abstract][Full Text] [Related]
16. Prospects, including time-frames, for improved foot and mouth disease vaccines.
Grubman MJ; Mason PW
Rev Sci Tech; 2002 Dec; 21(3):589-600. PubMed ID: 12523699
[TBL] [Abstract][Full Text] [Related]
17. Foot and mouth disease outbreak investigation and estimation of its economic impact in selected districts in northwest Ethiopia.
Tadesse B; Tesfahun A; Molla W; Demisse E; Jemberu WT
Vet Med Sci; 2020 Feb; 6(1):122-132. PubMed ID: 31710180
[TBL] [Abstract][Full Text] [Related]
18. The effect of foot-and-mouth disease (FMD) vaccination on virus transmission and the significance for the field.
Orsel K; Bouma A
Can Vet J; 2009 Oct; 50(10):1059-63. PubMed ID: 20046605
[TBL] [Abstract][Full Text] [Related]
19. Foot and mouth disease.
Davies G
Res Vet Sci; 2002 Dec; 73(3):195-9. PubMed ID: 12443674
[TBL] [Abstract][Full Text] [Related]
20. Adjuvants for foot-and-mouth disease virus vaccines: recent progress.
Cao Y
Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
